Frequently Asked Questions

Conference Speakers

Cultural Speakers

Cultural practices, beliefs, and norms play a very important role not only in delivering health care to clients and patients, but also in how that health care is received and what outcomes are possible. Diversity within those beliefs and practices, and as a result of available resources or social economic/demographic circumstances, must be fully understood in order for health care professionals to provide the best care possible no matter where they are in the world, or what culture they are practicing within.

At GOLD Perinatal Care, we understand the importance of Culture and Diversity in health care, and we are working hard to bring you speakers and presentations from around the world that will help you understand the patients and clients you are working with. Discovering how health care is provided and received in other countries and cultures around the world can have a positive impact on our own professional practice. Given that culture is defined by much more than political borders, GOLD Perinatal Care invites speakers to share their knowledge and expertise about perinatal health care from a geographically-based focus or a people-group focus from within a particular set of beliefs, lifestyle or minority. This year, our Culture and Diversity speakers will be presenting on:

- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Dr. Second Speaker Name
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
View Registration Info
Speakers

Speakers (5191)

Sunday, 08 August 2021 11:17

Shuji Sakai

Written by
Sunday, 08 August 2021 11:17

Leopoldo Segal

Written by
Dr. Segal is director of the Lung Microbiome Program, and an associate professor of medicine at NYU Grossman School of Medicine. He received his MD from Universidad Nacional de La Plata, Argentina, and his Master of Science from New York University. Dr. Segal is the principal investigator of multiple projects obtaining lower airway samples through research bronchoscopies as well as through clinically-indicated bronchoscopy. These projects include subjects with different pulmonary conditions wherein multiple culture-independent assays can be used to uncover bacteria presence in the lower airways and elucidate how they affect the host immune tone.
Sunday, 08 August 2021 11:17

Jennifer Beane

Written by
Jennifer Beane is an Assistant Professor at Boston University School of Medicine in the Section of Computational Biomedicine. Her research focuses on developing and applying computational methods to improve lung cancer risk stratification, early detection of lung cancer, and the development of new lung cancer chemoprevention strategies. She has contributed to research characterizing gene expression and cell population abundance changes in the airway field of injury associated with smoking and smoking cessation. She was involved in work leveraging the airway field of injury to develop a gene expression-based biomarker for the detection of lung cancer in patients undergoing bronchoscopy for suspicion of lung cancer. Research from her lab has also described alterations in lung squamous bronchial premalignant lesions and identified immune suppression mechanisms associated with lesion progression.
Sunday, 08 August 2021 11:17

Alex Bui

Written by
Dr. Bui is the Director of the Medical & Imaging Informatics (MII) Group at UCLA and holds the David Geffen Chair in Informatics.
Dr. Bui’s research includes informatics and data science for biomedical research and healthcare in areas related to distributed information architectures and mHealth; development, evaluation, and translation of AI-based methods (e.g., machine learning, reinforcement learning) for healthcare; and data visualization. His work bridges contemporary computational approaches with the opportunities arising from the breadth of biomedical observations and the electronic health record (EHR), tackling the associated translational challenges. In particular, his research looks to develop new ways to use both large-scale observational datasets and newer types of observations to improve aspects of cancer screening and diagnosis through more individually-tailored approaches.
Sunday, 08 August 2021 11:17

TaCharra Woodard

Written by
TaCharra Woodard is an Acute Care Nurse Practitioner in Thoracic and Cardiovascular Surgery at the University of Texas M.D. Anderson Cancer Center in Houston, Texas. She has practiced with this division since 2013 and has worked in the organization since 2006. Ms. Woodard has predominantly served the oncologic population as a nurse practitioner since 2001. Ms. Woodard earned her Bachelor of Science in Nursing from Tennessee State University and Master's of Science in Nursing from Vanderbilt University. She has been a nurse for 25 years. Her areas of interest are Enhanced Recovery After Surgery and opioid stewardship postoperatively.
Sunday, 08 August 2021 11:17

Nicole Kiss

Written by
Associate Professor Nicole Kiss is an advanced APD with more than 20 years’ experience in cancer nutrition including clinical, research and health service management positions. Nicole is a Victorian Cancer Agency Clinical Research Fellow and co-lead of the Exercise and Nutrition for Cancer research group in the Institute for Physical Activity and Nutrition at Deakin University, Australia. Nicole’s research interests include interventions to optimize nutritional and functional outcomes during and after cancer therapy with a particular focus on body composition.
Sunday, 08 August 2021 11:17

Ashlee Mulimba

Written by
Dr Ashlee Mulimba, is a Chartered Health Psychologist with Healthy Dialogues. Ashlee has a special interest in behaviour change and behavioural science approaches to improving the health and wellbeing of individuals, communities and populations. Ashlee has been training the cancer workforce in Motivational Interviewing for over 15 years.
Sunday, 08 August 2021 11:17

Jacqui Frowen

Written by
Jacqui is the Clinical Lead of the Speech Pathology team at Peter Mac in Melbourne, Australia. She has worked as a speech pathologist with a special interest in oncology for over 20 years and she now leads the busy clinical service at Peter Mac, with a team of 6 speech pathologists across two sites. Jacqui completed her PhD in 2009 and since this time has continued to conduct clinical research in communication and swallowing outcomes after cancer treatment, with a specific focus on head & neck and lung cancers. Jacqui is a regular invited lecturer at the University of Melbourne and La Trobe University on various topics in swallowing disorders, head and neck cancer and tracheostomy management.
Sunday, 08 August 2021 11:17

Somaya Abou-Abdou

Written by
Professor of Psychiatric & Mental Health Nursing, The ex- Dean Faculty of Nursing, Suez Canal University, Ismailia. Egypt. Now the Vice Dean, Post- graduate and Research Affairs, also the Head of Psychiatric and mental health nursing department. Visiting Scientist, Queen’s University School of Nursing, Kingston, ON Canada. A consultant in Nursing Education for Maastricht University, The contact person & member of the Tuning project (TEMPUS) "Tuning Middle East and North Africa". Active Membership of Psycho‐Oncology Society . Reviewer of many international & national Journals for example in Archives of Psychiatric Nursing Journal the editor the faculty of nursing scientific journal. My research interest in oncology area, community & Psychiatry mental health Nursing, human sexuality & Psych-Oncology Nursing.
Sunday, 08 August 2021 11:17

Biniam Kidane

Written by
Dr. Kidane is a Thoracic Surgeon with a special interest in minimally invasive and endoscopic approaches to benign and malignant thoracic/foregut disease. He completed his MD at the University of Toronto and his General Surgery Residency at Western University. He then completed Thoracic Surgery Residency at the University of Toronto. During this time, he benefited from the mentorship of global leaders in the fields of Thoracic Oncology (Dr Gail Darling) and Interventional Pulmonary Endoscopy (Dr Kazuhiro Yasufuku). He had the privilege of pursuing further training in Interventional Endoscopy at McGill with Dr Lorenzo Ferri and at the CHUM (Centre hospitalier de l'Université de Montréal) with Dr Moishe Liberman.
Dr. Kidane joined the Department of Surgery at the University of Manitoba in 2016. Since that time, he has established the Endoscopic Submucosal Resection program in Manitoba for incision-less treatment of esophageal cancer. He established the Non-Intubated VATS (Video-Assisted Thoracic Surgery) program in Manitoba, which has increased access to this modality for the management of high-risk thoracic patients as well as patients with malignant pleural effusions. All of these treatments are now being offered as outpatient therapy in the Wilf Tailleu Thoracic Endoscopy Clinic. Dr Kidane has a research interest in peri-operative care specifically in the thoracic surgery sphere but also in all surgical disciplines. His major interest is in lung protective ventilation during thoracic surgery as well as peri-operative practice variation and quality improvement. He also has a research interest in health services and outcomes research as it relates to esophageal and lung cancer. A major focus of his esophageal cancer research is in health-related quality of life. Esophageal cancer is a devastating illness with historically poor survival; furthermore, the treatment of esophageal cancer can also be difficult and cause significant reductions in the quality of life of patients with esophageal cancer. Dr Kidane’s program of research in esophageal cancer brings together elements of surgical quality, patient quality of life, oncologic outcomes and health resource utilization with the ultimate goal of identifying the right treatment for the right patient at the right time.
Page 350 of 371